Neurocutaneous Syndromes in Children: Prevalence and Clinical Characteristics
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorAssiut University
About this trial
This cross-sectional study aims to determine the prevalence, clinical characteristics, and management patterns of neurocutaneous syndromes among children attending the Pediatric Neurology Unit at Assiut University.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from birth to 18 years
Diagnosis of neurocutaneous syndrome according to established clinical and/or genetic diagnostic criteria
Written informed consent from parents or legal guardians
Disqualifiers
Uncertain diagnosis
Incomplete medical records
Refusal of parents or legal guardians to participate
Trial population
Children aged from birth to 18 years diagnosed with neurocutaneous syndromes attending the Pediatric Neurology Unit (outpatient or inpatient) at Assiut University during the study period.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: Single cohort: Children with neurocutaneous syndromes
Trial outcomes
Primary outcomes
1
Prevalence of Neurocutaneous Syndromes Among Pediatric Neurology Patients
Proportion of children diagnosed with neurocutaneous syndromes among all patients attending the Pediatric Neurology Unit during the study period. Prevalence calculated as number of NCS cases divided by total number of pediatric neurology attendees during the same period.
Time frame
Baseline2
Distribution of Neurofibromatosis Type 1
Frequency and percentage of Neurofibromatosis type 1 among diagnosed neurocutaneous syndrome cases.
Time frame
Baseline3
Distribution of Neurofibromatosis Type 2
Frequency and percentage of Neurofibromatosis type 2 among diagnosed neurocutaneous syndrome cases.
Time frame
Baseline4
Distribution of Tuberous Sclerosis Complex
Frequency and percentage of Tuberous Sclerosis Complex among diagnosed neurocutaneous syndrome cases.
Time frame
BaselineSecondary outcomes
1
Cutaneous Manifestations
Frequency and percentage of cutaneous manifestations among children with neurocutaneous syndromes, assessed by clinical examination.
Time frame
Baseline2
Epilepsy
Frequency and percentage of epilepsy among children with neurocutaneous syndromes, assessed by clinical examination and EEG.
Time frame
Baseline3
Developmental Delay
Frequency and percentage of developmental delay among children with neurocutaneous syndromes, assessed by clinical examination.
Time frame
Baseline4
Intellectual Disability
Frequency and percentage of intellectual disability among children with neurocutaneous syndromes, assessed by clinical examination.
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: